• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Environ Res Public Health . Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam

tetano

Editor, Senior Moderator
Int J Environ Res Public Health


. 2021 Jun 11;18(12):6353.
doi: 10.3390/ijerph18126353.
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam


Tasnim Hasan[SUP] 1 2 [/SUP], Thach Ngoc Pham[SUP] 3 [/SUP], Thu Anh Nguyen[SUP] 2 [/SUP], Hien Thi Thu Le[SUP] 2 [/SUP], Duyet Van Le[SUP] 3 [/SUP], Thuy Thi Dang[SUP] 3 [/SUP], Trang Dinh Van[SUP] 3 [/SUP], Yen Ngoc Pham[SUP] 2 [/SUP], Ha Viet Nguyen[SUP] 2 [/SUP], Giang Linh Tran[SUP] 2 [/SUP], Van Thi Cam Nguyen[SUP] 2 [/SUP], Thanh Trung Nguyen[SUP] 2 [/SUP], Viet Quang Truong[SUP] 4 [/SUP], Than Huu Dao[SUP] 4 [/SUP], Chung Thanh Le[SUP] 5 [/SUP], Nam Tan Truong[SUP] 5 [/SUP], Hoang Trung Vo[SUP] 6 [/SUP], Phuc Thanh Le[SUP] 7 [/SUP], Thao Thanh Nguyen[SUP] 8 [/SUP], Vinh Van Luu[SUP] 8 [/SUP], Vinh Dai Nguyen[SUP] 9 [/SUP], Brett G Toelle[SUP] 1 2 10 [/SUP], Guy B Marks[SUP] 2 11 [/SUP], Greg J Fox[SUP] 1 2 [/SUP]



Affiliations

Abstract

As a response to the coronavirus disease 2019 (COVID-19) pandemic, Vietnam enforced strict quarantine, contact tracing and physical distancing policies resulting in one of the lowest numbers of individuals infected with severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) globally. This study aimed to determine the prevalence of SARS-CoV-2 antibody positivity among high-risk populations in Vietnam. A prevalence survey was undertaken within four communities in Vietnam, where at least two COVID-19 cases had been confirmed. Participants were classified according to the location of exposure: household contacts, close contacts, community members, and healthcare workers (HCWs) responsible for treating COVID-19 cases. Participants completed a baseline questionnaire and SARS-CoV-2 IgG antibodies were quantified using a commercial assay. A total of 3049 community members and 149 health care workers consented to the study. Among 13 individuals who were seropositive (0.4%), five household contacts (5/27, 18.5%), one close contact (1/53, 1.9%), and seven community members (7/2954, 0.2%) had detectable SARS-CoV-2 antibodies. All HCWs were negative for SARS-CoV-2 antibodies. Participants were tested a median of 15.1 (interquartile range from 14.9 to 15.2) weeks after exposure. Our study found a low prevalence of SARS-CoV-2 antibodies in high-risk communities and healthcare workers in communities in Vietnam with known COVID-19 cases.

Keywords: COVID-19; SARS-CoV-2; Vietnam; seroprevalence.
 
Back
Top Bottom